Partnership momentum Past leadership appointments and a history of collaboration with major players indicate a strong business development orientation; pursue pharma and diagnostics partnerships for co-development, licensing, or revenue-sharing around the injectable diagnostic platform.

Acquisition activity Recent corporate moves between Glympse and Sunbird suggest ongoing consolidation and integration opportunities; explore technology licensing, joint development, or cross-licensing to accelerate diagnostic capabilities.

Growth enablers With a small team and early-stage revenue supported by notable funding, there is a need for scalable lab automation, CRO support, and contract manufacturing partnerships to accelerate development and scale.

Data driven platform Tech stack including Benchling, Docker, SQL and Java shows readiness for integrated data workflows; ideal to pitch data management, cloud analytics, and lab software to support measuring protein activity.

Cambridge ecosystem Based in Cambridge MA, proximity to top universities and a dense biotech cluster creates local BD opportunities with research institutions, startups, and regional pharma partners.